Emergent BioSolutions to Participate in Jefferies Global Healthcare Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the Jefferies Global Healthcare Conference in London, November 16-19, 2026.

Management will present via webcast on November 18 at 8:00am – 8:25am UTC/GMT (3:00am ET). A replay of the presentation will be available on the webcast page linked above for approximately three months. Visit Emergent’s Investor Relations page to learn more. Please contact a conference representative to request a one-on-one meeting.

About Emergent BioSolutions

At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  268.19
+1.25 (0.47%)
AAPL  347.66
-3.03 (-0.86%)
AMD  502.79
-5.79 (-1.14%)
BAC  50.64
+0.09 (0.18%)
GOOG  283.50
-2.51 (-0.88%)
META  638.85
-2.52 (-0.39%)
MSFT  530.58
-14.60 (-2.68%)
NVDA  166.51
-12.16 (-6.81%)
ORCL  115.95
-3.84 (-3.21%)
TSLA  375.10
-2.95 (-0.78%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.